|
1
|
Stanford SM, Maestre MF, Campbell AM,
Bartok B, Kiosses WB, Boyle DL, Arnett HA, Mustelin T, Firestein GS
and Bottini N: Protein tyrosine phosphatase expression profile of
rheumatoid arthritis fibroblast-like synoviocytes: a novel role of
SH2 domain-containing phosphatase 2 as a modulator of invasion and
survival. Arthritis Rheum. 65:1171–1180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42.
2011. View Article : Google Scholar
|
|
3
|
Paula FS and Alves JD: Non-tumor necrosis
factor-based biologic therapies for rheumatoid arthritis: present,
future, and insights into pathogenesis. Biologics. 8:1–12.
2014.
|
|
4
|
Inoue J, Gohda J and Akiyama T:
Characteristics and biological functions of TRAF6. Adv Exp Med
Biol. 597:72–79. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun L, Deng L, Ea CK, Xia ZP and Chen ZJ:
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation
by BCL10 and MALT1 in T lymphocytes. Mol Cell. 14:289–301. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chung JY, Lu M, Yin Q, Lin SC and Wu H:
Molecular basis for the unique specificity of TRAF6. Adv Exp Med
Biol. 597:122–130. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee HS, Ka SO, Lee SM, Lee SI, Park JW and
Park BH: Overexpression of sirtuin 6 suppresses inflammatory
responses and bone destruction in mice with collagen-induced
arthritis. Arthritis Rheum. 65:1776–1785. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nam EJ, Kang JH, Sung S, Sa KH, Kim KH,
Seo JS, Kim JH, Han SW, Kim IS and Kang YM: A matrix
metalloproteinase 1-cleavable composite peptide derived from
transforming growth factor β-inducible gene h3 potently inhibits
collagen-induced arthritis. Arthritis Rheum. 65:1753–1763. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tarrant TK, Liu P, Rampersad RR, Esserman
D, Rothlein LR, Timoshchenko RG, McGinnis MW, Fitzhugh DJ, Patel DD
and Fong AM: Decreased Th17 and antigen-specific humoral responses
in CX3 CR1-deficient mice in the collagen- induced
arthritis model. Arthritis Rheum. 64:1379–1387. 2012. View Article : Google Scholar
|
|
10
|
Nishikawa M, Myoui A, Tomita T, Takahi K,
Nampei A and Yoshikawa H: Prevention of the onset and progression
of collagen-induced arthritis in rats by the potent p38
mitogen-activated protein kinase inhibitor FR167653. Arthritis
Rheum. 48:2670–2681. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aletaha D, Neogi T, Silman AJ, et al: 2010
Rheumatoid arthritis classification criteria: an American College
of rheumatology/european league against rheumatism collaborative
initiative. Arthritis Rheum. 62:2569–2581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dale J, Purves D, McConnachie A, McInnes I
and Porter D: Tightening up? Impact of musculoskeletal ultrasound
disease activity assessment on early rheumatoid arthritis patients
treated using a treat to target strategy. Arthritis Care Res
(Hoboken). 66:19–26. 2014. View Article : Google Scholar
|
|
13
|
Yoshioka Y, Kozawa E, Urakawa H, Arai E,
Futamura N, Zhuo L, Kimata K, Ishiguro N and Nishida Y: Suppression
of hyaluronan synthesis alleviates inflammatory responses in murine
arthritis and in human rheumatoid fibroblasts. Arthritis Rheum.
65:1160–1170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee A, Qiao Y, Grigoriev G, Chen J,
Park-Min KH, Park SH, Ivashkiv LB and Kalliolias GD: Tumor necrosis
factor α induces sustained signaling and a prolonged and
unremitting inflammatory response in rheumatoid arthritis
fibroblasts. Arthritis Rheum. 65:928–938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laragione T, Brenner M, Sherry B and Gulko
PS: CXCL10 and its receptor CXCR3 regulate synovial fibroblast
invasion in rheumatoid arthritis. Arthritis Rheum. 63:3274–3283.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
García-Vicuña R, Gómez-Gaviro MV,
Domínguez-Luis MJ, Pec MK, González-Alvaro I, Alvaro-Gracia JM and
Díaz-González F: CC and CXC chemokine receptors mediate migration,
proliferation, and matrix metalloproteinase production by
fibroblast-like synoviocytes from rheumatoid arthritis patients.
Arthritis Rheum. 50:3866–3877. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cooles FA and Isaacs JD: Pathophysiology
of rheumatoid arthritis. Curr Opin Rheumatol. 23:233–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muto G, Kotani H, Kondo T, Morita R,
Tsuruta S, Kobayashi T, Luche H, Fehling HJ, Walsh M, Choi Y and
Yoshimura A: TRAF6 is essential for maintenance of regulatory T
cells that suppress Th2 type autoimmunity. PLoS One. 8:e746392013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Namjou B, Choi CB, Harley IT and
Alarcón-Riquelme ME; BIOLUPUS Network. Kelly JA, Glenn SB, et al:
Evaluation of TRAF6 in a large multiancestral lupus cohort.
Arthritis Rheum. 64:1960–1969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muto G, Kotani H, Kondo T, Morita R,
Tsuruta S, Kobayashi T, Luche H, Fehling HJ, Walsh M, Choi Y and
Yoshimura A: TRAF6 is essential for maintenance of regulatory T
cells that suppress Th2 type autoimmunity. PLoS One. 8:e746392013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park JS, Lim MA, Cho ML, Ryu JG, Moon YM,
Jhun JY, Byun JK, Kim EK, Hwang SY, Ju JH, Kwok SK and Kim HY: p53
controls autoimmune arthritis via STAT-mediated regulation of the
Th17 cell/Treg cell balance in mice. Arthritis Rheum. 65:949–959.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moon YM, Lee J, Lee SY, Her YM, Ryu JG,
Kim EK, Son HJ, Kwok SK, Ju JH, Yang CW, Park SH, Kim HY and Cho
ML: Gene-associated retinoid-interferon- induced mortality 19
(GRIM-19) attenuates autoimmune arthritis by regulation of Th17 and
Treg cells. Arthritis Rheum. 18:2013.
|
|
23
|
Konno H, Yamamoto T, Yamazaki K, Gohda J,
Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, et al: TRAF6
establishes innate immune responses by activating NF-kappaB and
IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One.
4:e56742009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bamborough P, Morse MA and Ray KP:
Targeting IKKβ for the treatment of rheumatoid arthritis. Drug News
Perspect. 23:483–490. 2010.PubMed/NCBI
|
|
25
|
Wei ZF, Tong B, Xia YF, Lu Q, Chou GX,
Wang ZT and Dai Y: Norisoboldine suppresses osteoclast
differentiation through preventing the accumulation of TRAF6-TAK1
complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 pathways. PLoS
One. 8:e591712013. View Article : Google Scholar
|
|
26
|
Lee HJ, Jang SH, Kim H, Yoon JH and Chung
KC: PINK1 stimulates interleukin-1β-mediated inflammatory signaling
via the positive regulation of TRAF6 and TAK1. Cell Mol Life Sci.
69:3301–3315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maruotti N, Grano M, Colucci S, d’Onofrio
F and Cantatore FP: Osteoclastogenesis and arthritis. Clin Exp Med.
11:137–145. 2011. View Article : Google Scholar
|
